Nano-X Imaging Ltd. (NNOX) stock forecast & analysis
0.3184
NasdaqGM · USDDelayed by 15 minutes
Down: -0.0455, -12.5%
1 analysis
Latest analysis: · verdict locked
- Open
- 0.3711
- Previous close
- 0.3639
- Day range
- 0.3103 – 0.3756
- 52-week range
- 0.2070 – 4.71
- Volume (shares)
- 2.64M
- Net assets
- Not available
- Expense ratio
- Not available
- Shares outstanding
- 78.75M
- P/E ratio
- Not available
- Dividend yield
- 0.00%
- Beta
- 1.36
- Market cap
- 25.07M
Market Scanner’s AI analysis of Nano-X Imaging Ltd. (NNOX), updated November 2026: Nano-X Imaging Ltd. (NNOX) commercial expansion and AI integration contrasted with significant revenue losses and negative profitability.
This page is the public summary. A signed-in user can run a fresh five-stage AI analysis of Nano-X Imaging Ltd. (NNOX) and read the full verdict with the bull and bear debate behind it — using Market Scanner tokens, or their own OpenAI or Anthropic key.
Summary
Nano-X Imaging Ltd. (NNOX) commercial expansion and AI integration contrasted with significant revenue losses and negative profitability.
Recent analyses for Nano-X Imaging Ltd. (NNOX) covered strategic commercial expansions, including AI cardiac solutions in Thailand and enhanced teleradiology workflows through partnerships. These developments were juxtaposed with significant financial headwinds, characterized by substantial revenue shortfalls relative to costs, consistently negative operating and net income, and a declining stock price trend over longer periods despite a recent short-term uptick.
NNOX news & sentiment
News coverage highlighted Nano-X Imaging's strategic commercial advancements and AI integration efforts in new markets and partnerships. Social media discussion was not explicitly covered in the provided notes.
NNOX technical picture
Nano-X Imaging Ltd. (NNOX) has seen a recent short-term price increase, though longer-term trends show significant declines. Momentum indicators present a mixed picture, with some suggesting overbought conditions while others indicate bearish momentum, and the price remains well below key moving averages.
Fundamentals
Revenue has shown an increasing trend annually, though quarterly revenue growth was offset by a significant cost of revenue, resulting in negative gross profit. The company has consistently reported negative operating and net income, with a substantial operating margin deficit and negative return on equity.
Factors discussed — upside
- Quarterly revenue growth year-over-year was 36.7%.
- Annual revenue has shown an increasing trend from 2022 to 2025.
- Commercial collaboration to introduce an AI cardiac solution to Thailand.
- Expansion of collaboration to integrate FDA-cleared X-ray AI into teleradiology workflows.
- Clinical data revealed potential utility and market need for Nanox.AI's AVC solution.
Factors discussed — risks
- Gross profit was negative for the quarter ending June 30, 2026.
- Consistently reported negative operating and net income.
- Operating Margin TTM is -653.3%.
- Return on Equity TTM is -99%.
- Stock price is significantly below 50-day and 200-day SMAs, indicating a longer-term downtrend.
- Commercial Expansion
- AI Integration
- Financial Performance
- Market Need
Summary updated .
NNOX technical indicators
Common technical indicators for NNOX, computed from its daily closing prices.
| Indicator | Value | Reading |
|---|---|---|
| 50-day simple moving average | 0.54 | Price below |
| 10-day exponential moving average | 0.32 | Price above |
| Relative strength index (14-day) | 39.51 | Neutral |
| MACD line (12/26/9) | -0.0679 | Above its signal line |
| Bollinger bands (20-day, 2σ) | 0.22 – 0.45 | Price inside the bands |
Analyses
Recent NNOX.US analyses are locked — sign in to read them or generate a fresh one.
Locked
Unlock in the library — 1 newer report
Sign in to unlock the 2026-11-11 NNOX.US analysis
Get the verdict — free
Frequently asked questions
- What is the bull case for Nano-X Imaging Ltd.?
- Recent analyses highlighted Nano-X Imaging Ltd.'s strategic commercial expansions, including AI cardiac solutions in Thailand and enhanced teleradiology workflows through partnerships, alongside clinical data suggesting market need for its AI solutions. The company also demonstrated year-over-year quarterly revenue growth and an increasing annual revenue trend.
- What are the risks for Nano-X Imaging Ltd.?
- The analyses noted significant financial headwinds for Nano-X Imaging Ltd., including negative gross profit for the latest reported quarter, consistently negative operating and net income, and a deeply negative operating margin and return on equity. The stock price also showed a longer-term downtrend, trading significantly below its 50-day and 200-day moving averages.
- Is Nano-X Imaging Ltd. bullish or bearish?
- Recent AI analyses of Nano-X Imaging Ltd. examined factors on both sides. Discussed upside: Recent analyses highlighted Nano-X Imaging Ltd.'s strategic commercial expansions, including AI cardiac solutions in Thailand and enhanced teleradiology workflows through partnerships, alongside clinical data suggesting market need for its AI solutions. The company also demonstrated year-over-year quarterly revenue growth and an increasing annual revenue trend. Discussed risks: The analyses noted significant financial headwinds for Nano-X Imaging Ltd., including negative gross profit for the latest reported quarter, consistently negative operating and net income, and a deeply negative operating margin and return on equity. The stock price also showed a longer-term downtrend, trading significantly below its 50-day and 200-day moving averages. These are descriptive observations, not a recommendation.
- What is the latest sentiment on Nano-X Imaging Ltd.?
- News coverage highlighted Nano-X Imaging's strategic commercial advancements and AI integration efforts in new markets and partnerships. Social media discussion was not explicitly covered in the provided notes.
- How does Market Scanner analyse Nano-X Imaging Ltd.?
- Every analysis of Nano-X Imaging Ltd. runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.Read the methodology
What is the bull case for Nano-X Imaging Ltd.?
Recent analyses highlighted Nano-X Imaging Ltd.'s strategic commercial expansions, including AI cardiac solutions in Thailand and enhanced teleradiology workflows through partnerships, alongside clinical data suggesting market need for its AI solutions. The company also demonstrated year-over-year quarterly revenue growth and an increasing annual revenue trend.
What are the risks for Nano-X Imaging Ltd.?
The analyses noted significant financial headwinds for Nano-X Imaging Ltd., including negative gross profit for the latest reported quarter, consistently negative operating and net income, and a deeply negative operating margin and return on equity. The stock price also showed a longer-term downtrend, trading significantly below its 50-day and 200-day moving averages.
Is Nano-X Imaging Ltd. bullish or bearish?
Recent AI analyses of Nano-X Imaging Ltd. examined factors on both sides. Discussed upside: Recent analyses highlighted Nano-X Imaging Ltd.'s strategic commercial expansions, including AI cardiac solutions in Thailand and enhanced teleradiology workflows through partnerships, alongside clinical data suggesting market need for its AI solutions. The company also demonstrated year-over-year quarterly revenue growth and an increasing annual revenue trend. Discussed risks: The analyses noted significant financial headwinds for Nano-X Imaging Ltd., including negative gross profit for the latest reported quarter, consistently negative operating and net income, and a deeply negative operating margin and return on equity. The stock price also showed a longer-term downtrend, trading significantly below its 50-day and 200-day moving averages. These are descriptive observations, not a recommendation.
What is the latest sentiment on Nano-X Imaging Ltd.?
News coverage highlighted Nano-X Imaging's strategic commercial advancements and AI integration efforts in new markets and partnerships. Social media discussion was not explicitly covered in the provided notes.
How does Market Scanner analyse Nano-X Imaging Ltd.?
Every analysis of Nano-X Imaging Ltd. runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.
Read the methodology- Bundles used
- gemini-low-v2
Run a fresh NNOX.US analysis
Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.